Cervical human papillomavirus screening by PCR: advantages of targeting the E6/E7 region

References

1. Walboomers JM, Jacobs MV, Manos MM, Bosch F, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12–9.10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-FSearch in Google Scholar

2. Bosch FX, Manos MM, Munoz M, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995; 87:796–802.10.1093/jnci/87.11.796Search in Google Scholar

3. Turek LP. The structure, function, and regulation of papillomaviral genes in infection and cervical cancer. Adv Virus Res 1994; 44:305–56.10.1016/S0065-3527(08)60332-2Search in Google Scholar

4. Dowhanick JJ, McBride AA, Lowly PM. Suppression of cellular proliferation by the papillomavirus E2 protein. J Virol 1995; 69:7791–9.10.1128/jvi.69.12.7791-7799.1995Search in Google Scholar

5. Kobayashi Y, Yoshinouchi M, Tianqi G, Nakamura K, Hongo A, Kamimura S, et al. Presence of human papillomavirus DNA in pelvic lymph nodes can predict unexpected recurrence of cervical cancer in patients with histologically negative lymph nodes. Clin Cancer Res 1998; 4:979–83.Search in Google Scholar

6. Cullen AP, Reid R, Campion M, Lorincz A. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasms. J Virol 1991; 65:606–12.10.1128/jvi.65.2.606-612.1991Search in Google Scholar

7. Das BC, Sharma JK, Gopalakrishna V, Luthra UK. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J Gen Virol 1992; 73:2327–36.10.1099/0022-1317-73-9-2327Search in Google Scholar

8. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 1984; 3:1151–7.10.1002/j.1460-2075.1984.tb01944.xSearch in Google Scholar

9. Howley PM. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 1985; 119:361–6.Search in Google Scholar

10. Yee C, Krishnan-Hewlett I, Backer CC, Schlegal R, Howley PM. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 1985; 119:361–6.Search in Google Scholar

11. Tsunokawa Y, Takebe N, Nozawa S, Kasamatsu T, Gissmann L, zur Hausen H, et al. Presence of human papillomavirus type-16 and type-18 DNA sequences and their expression in cervical cancers and cell lines from Japanese patients. Int J Cancer 1986; 37:499–503.10.1002/ijc.2910370405Search in Google Scholar

12. Vernon DD, Unger ER, Miller DL, Lee DR, Reeves WC. Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival from cervical cancer. Int J Cancer 1997; 74:50–6.10.1002/(SICI)1097-0215(19970220)74:1<50::AID-IJC9>3.0.CO;2-#Search in Google Scholar

13. Dürst M, Kleinheinz A, Hotz M, Gissman L. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol 1985; 66:1515–22.10.1099/0022-1317-66-7-1515Search in Google Scholar

14. Yiu KC, Huang DP, Chan MK, Foo W. The physical state of human papillomavirus type 16 DNA in cervical carcinomas of Hong Kong Chinese. Oncogene 1991; 6:1339–42.Search in Google Scholar

15. Matsukura T, Koi S, Sugase M. Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology 1989; 172:63–72.10.1016/0042-6822(89)90107-4Search in Google Scholar

16. Watts KJ, Thompson CH, Cossart YE, Rose BR. Sequence variation and physical state of human papillomavirus type 16 cervical cancer isolates from Australia and New Caledonia. Int J Cancer 2002; 97:868–74.10.1002/ijc.10103Search in Google Scholar

17. Peitsaro P, Johansson B, Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 2002; 40:886–91.10.1128/JCM.40.3.886-891.2002Search in Google Scholar

18. Schwarz E, Freese U, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985; 314:111–14.10.1038/314111a0Search in Google Scholar

19. Fukushima M, Yamakawa Y, Shimano S, Hashimoto M, Sawada Y, Fujinaga K. The physical state of human papillomavirus 16 DNA in cervical carcinoma and cervical intraepithelial neoplasia. Cancer 1990; 66:2155–61.10.1002/1097-0142(19901115)66:10<2155::AID-CNCR2820661019>3.0.CO;2-QSearch in Google Scholar

20. Park JS, Hwang ES, Park SN, Ahn HK, Um SJ, Kim CJ, et al. Physical status and expression of HPV genes in cervical cancers. Gynecol Oncol 1997; 65:121–9.10.1006/gyno.1996.4596Search in Google Scholar

21. Pfister H, Fuchs PG. Relation of papillomaviruses to anogenital cancer. Dermatol Clin 1991; 9:267–76.10.1016/S0733-8635(18)30415-7Search in Google Scholar

22. Shirasawa H, Tomita Y, Kubota K, Kasai T, Sekiya S, Takamizawa H, et al. Detection of human papillomavirus type 16 DNA and evidence for integration into the cell DNA in cervical dysplasia. J Gen Virol 1986; 67:2011–5.10.1099/0022-1317-67-9-2011Search in Google Scholar

23. Andersson S, Safari H, Mints M, Lewensohn-Fuchs I, Gyllensten U, Johansson B. Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN). Br J Cancer 2005; 92:2195–200.10.1038/sj.bjc.6602648Search in Google Scholar

24. Shirasawa H, Tomita Y, Sekiya S, Takamizawa H, Simizu B. Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas. J Gen Virol 1987; 68:583–91.10.1099/0022-1317-68-2-583Search in Google Scholar

25. Choo KV, Pan CC, Han SH. Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology 1987; 161:259–61.10.1016/0042-6822(87)90195-4Search in Google Scholar

26. Matsukura T, Kanda T, Furuno A, Yoshikawa H, Kawana T, Yoshiike K. Cloning of monomeric human papillomavirus type 16 DNA integrated within cell DNA from a cervical carcinoma. J Virol 1986; 58:979–82.10.1128/jvi.58.3.979-982.1986Search in Google Scholar PubMed PubMed Central

27. Schneider-Maunoury S, Croissant O, Orth G. Integration of human papillomavirus type 16 DNA sequences: a possible early event in the progression of genital tumours. J Virol 1987; 61:3295–8.10.1128/jvi.61.10.3295-3298.1987Search in Google Scholar

28. Wagatsuma M, Hashimoto K, Matsukura T. Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: amplification of viral sequences together with cellular flanking sequences. J Virol 1990; 64:813–21.10.1128/jvi.64.2.813-821.1990Search in Google Scholar

29. Jeon S, Allen-Hoffmann BL, Lambert PF. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 1995; 69:2989–97.10.1128/jvi.69.5.2989-2997.1995Search in Google Scholar

30. Cone RW, Minson AC, Smith MR, McDougall JK. Conservation of HPV-16 E6/E7 ORF sequences in a cervical carcinoma. J Med Virol 1992; 37:99–107.10.1002/jmv.1890370205Search in Google Scholar PubMed

31. Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, Howley PM. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 1987; 61:962–71.10.1128/jvi.61.4.962-971.1987Search in Google Scholar

32. Choo KB, Lee HH, Pan CC, Wu SM, Liew LN, Cheung WF, et al. Sequence duplication and internal deletion in the integrated human papillomavirus type 16 genome cloned from a cervical carcinoma. J Virol 1988; 62:1659–66.10.1128/jvi.62.5.1659-1666.1988Search in Google Scholar PubMed PubMed Central

33. Jeon S, Lambert PF. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci USA 1995; 92:1654–8.10.1073/pnas.92.5.1654Search in Google Scholar PubMed PubMed Central

34. Romanczuk H, Thierry F, Howley PM. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P99 and type 18 P105 promoters. J Virol 1990; 64:5240–9.10.1128/jvi.64.6.2849-2859.1990Search in Google Scholar PubMed PubMed Central

35. Thierry F, Howley PM. Functional analysis of E2 mediated repression of the HPV 18 P105 promoter. New Biol 1991; 3:90–100.Search in Google Scholar

36. Bernard BA, Bailly C, Lenoir MC, Darmon M, Thierry F, Yaniv M. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV 18 regulatory region in human keratinocytes. J Virol 1989; 63:4317–24.10.1128/jvi.63.10.4317-4324.1989Search in Google Scholar

37. Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G, Holm R, et al. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol 1996; 34:2095–100.10.1128/jcm.34.9.2095-2100.1996Search in Google Scholar

38. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989; 7:209–14.Search in Google Scholar

39. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995; 76:1057–62.10.1099/0022-1317-76-4-1057Search in Google Scholar

40. Snijders PJ, van den Brule AJ, Schrijnemakers HF, Snow G, Meijer CJ, Walboomers JM. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol 1990; 71:173–81.10.1099/0022-1317-71-1-173Search in Google Scholar

41. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Inf Dis 1994; 169:235–40.10.1093/infdis/169.2.235Search in Google Scholar

42. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38:357–61.10.1128/JCM.38.1.357-361.2000Search in Google Scholar

43. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS, et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 1997; 35:1304–10.10.1128/jcm.35.6.1304-1310.1997Search in Google Scholar

44. Coutlée F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N, et al. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 2002; 40:902–7.10.1128/JCM.40.3.902-907.2002Search in Google Scholar

45. Kleter B, van Doorn LJ, ter Schegget J, Schrauwen L, van Krimpen K, Burger M, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998; 153:1731–9.10.1016/S0002-9440(10)65688-XSearch in Google Scholar

46. Perrons C, Kleter B, Jelley R, Jalal H, Quint W, Tedder R. Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic. J Med Virol 2002; 67:246–52.10.1002/jmv.2214Search in Google Scholar PubMed

47. Monsonego J, Bohbot JM, Pollini G, Krawec C, Vincent C, Merignargues I, et al. Performance of the Roche AMPLICOR® Human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear. Gynecol Oncol 2005; July.10.1016/j.ygyno.2005.05.030Search in Google Scholar

48. Gregoire L, Arella M, Campione-Piccardo J, Lancaster WD. Amplification of human papillomavirus DNA sequences by using conserved primers. J Clin Microbiol 1989; 27:2660–5.10.1128/jcm.27.12.2660-2665.1989Search in Google Scholar

49. Morris BJ, Flanagan JL, McKinnon KJ, Nightingale BN. Papillomavirus screening of cervical lavages by polymerase chain reaction. Lancet 1988; ii:1368.10.1016/S0140-6736(88)90906-3Search in Google Scholar

50. Dallas PB, Flanagan JL, Nightingale BN, Morris BJ. Polymerase chain reaction for fast, nonradioactive detection of high- and low-risk papillomavirus types in routine cervical specimens and in biopsies. J Med Virol 1989; 27:105–11.10.1002/jmv.1890270207Search in Google Scholar

51. Morris BJ, Rose BR, Flanagan JL, McKinnon KJ, Loo CY, Thompson CH, et al. Automated polymerase chain reaction for papillomavirus screening of cervicovaginal lavages: comparison with dot-blot hybridization in a sexually transmitted diseases clinic population. J Med Virol 1990; 32:22–30.10.1002/jmv.1890320105Search in Google Scholar

52. Venturoli S, Bonvicini F, Cricca M, Gallinella G, Giosa F, Farinazzo F, et al. Evaluation of commercial kits for the detection and typing of human papillomavirus in cervical swabs. J Virol Methods 2002; 105:49–56.10.1016/S0166-0934(02)00066-6Search in Google Scholar

53. Schlecht NF, Trevisan A, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, et al. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer 2003; 103:519–24.10.1002/ijc.10846Search in Google Scholar PubMed

54. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992; 79:328–37.10.1097/00006250-199203000-00002Search in Google Scholar PubMed

55. Fujinaga Y, Shimada M, Okazawa K, Fukushima M, Kato I, Fujinaga K. Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol 1991; 72:1029–44.10.1099/0022-1317-72-5-1039Search in Google Scholar PubMed

56. Molijn A, Kleter B, Quint W, van Doorn LJ. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 2005; 32(Suppl 1):S43–S51.10.1016/j.jcv.2004.12.004Search in Google Scholar PubMed

57. Noffsinger AE, Suzuk L, Hui YZ, Gal AA, Fenoglio-Preiser CM. Differential sensitivities of E6 type-specific and L1 consensus primers in the detection of human papillomavirus in anal carcinoma. Mod Pathol 1995; 8:509–14.Search in Google Scholar

58. Park JS, Leake JF, Sharma BK, Toki T, Kessis TD, Ambros RA, et al. Variability in β-globin and HPV DNA amplification by PCR from fixed tissues. Mod Pathol 1991; 4:667–70.Search in Google Scholar

59. Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, Broker TR. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Human Pathol 1992; 23:117–28.10.1016/0046-8177(92)90232-RSearch in Google Scholar

60. Dürst M, Gallahan D, Jay G, Rhim JS. Glucocorticoid-enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene. Virology 1989; 173:767–71.10.1016/0042-6822(89)90595-3Search in Google Scholar

61. Munoz N, Bosch FX, de Sanjose S, Tafur L, Izarzugaza I, Gili M, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992; 52:743–9.10.1002/ijc.2910520513Search in Google Scholar

62. Eluf-Neto J, Booth M, Munoz N, Bosch FX, Meijer CJ, Walboomers JM. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994; 69:114–9.10.1038/bjc.1994.18Search in Google Scholar

63. Guerrero E, Daniel RW, Bosch FX, Castellsague X, Munoz N, Gili M, et al. Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. J Clin Microbiol 1992; 30:2951–9.10.1128/jcm.30.11.2951-2959.1992Search in Google Scholar

64. Smits HL, Bollen LJ, Tjong-A-Hung SP, Vonk J, Van Der Velden J, Ten Kate FJ, et al. Intermethod variation in detection of human papillomavirus DNA in cervical smears. J Clin Microbiol 1995; 33:2631–6.10.1128/jcm.33.10.2631-2636.1995Search in Google Scholar

65. Huang L-W, Chao S-L, Chen P-H, Chou H-P. Multiple HPV genotypes in cervical carcinomas: improved DNA detection and typing in archival tissues. J Clin Virol 2004; 29:271–6.10.1016/S1386-6532(03)00167-7Search in Google Scholar

66. Depuydt CE, Vereecken AJ, Salembier GM, Vanbrabant AS, Boels LA, van Herck E, et al. Thin-layer liquid-based cervical cytology and PCR for detecting and typing human papillomavirus DNA in Flemish women. Br J Cancer 2003; 88:560–6.10.1038/sj.bjc.6600756Search in Google Scholar PubMed PubMed Central